Global and USA Transdermal Drug Delivery Market to 2020

DUBLIN, Feb .18, 2015 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/xxttk5/global) has announced the addition of the "Global Transdermal Drug Delivery Market to 2020: Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and Swot Investigation" report to their offering.

This comprehensive report tackles problems that this vertical growing market faces and evaluates saturated sub-markets. A detailed outlay of its major players is performed including business strategy and future development analysis, merger and acquisition tactics, current product and pipeline entry evaluation and a detailed section on each player's financial situation. This analysis determines the unmet needs of the transdermal drug delivery industry and specific niche areas of market entry.

The transdermal drug delivery market has substantial associations within the smoking cessation market, analgesics/pain market, generics market, neuropathic pain market and also the women's health market. In the future it will enter the vaccine and gene therapy markets. Transdermal drug delivery is a complex area that has many driving factors including the unmet need for non-invasive drug delivery systems for pediatric, geriatric and dementia patients.

This report describes the current technologies that are propelling the market space and emerging trials and pipeline agents that will make a significant impact on the industry. It examines the current transdermal delivery systems and how generic competition is allowing penetration of new players in the market and saturation of niche areas.

Financial figures of the drug delivery market and the transdermal drug delivery space are revealed in this report. Forecast projections and future growth rates are provided to give the reader a forthcoming perspective of this growing industry. The study also provides a comprehensive financial, business strategy and product review of key players in the transdermal drug delivery industry. Strategic drivers and restraints of this market are revealed and market opportunities and challenges are identified.

In summary, the transdermal drug delivery market has huge opportunities for growth in the areas of dementia (Alzheimer's & Parkinson's Disease), generics, paediatrics and geriatrics. Currently the USA is the most prominent market place, followed by Europe, Asia and Emerging Markets. This report will reveal in-depth analysis of the industry and provide cutting-edge intelligence on the current and future spaces it will penetrate.

Key Topics Covered:

1.0 Executive Summary

2.0 Transdermal Drug Delivery

3.0 Biomechanical and Pharmacological Elements Effecting Transdermal Drug Delivery

4.0 Transdermal Drug Delivery Technologies

5.0 How Nanotechnology is Transforming Transdermal Drug Delivery

6.0 Transdermal Drug Delivery and Disease States

7.0 Gene Therapy and Transdermal Drug Delivery

8.0 Vaccines and Transdermal Drug Technology

9.0 Global Drug Delivery Market

10.0 Transdermal Drug Delivery Company Business Profiles and Strategic Evaluation

11.0 Transdermal Drug Delivery Company Financial Analysis

12.0 Current Transdermal Drug Delivery Products on the Market

13.0 In-Depth SWOT Analysis of the Transdermal Drug Delivery Market

Companies Mentioned

- Actavis
- Actelion
- GlaxoSmithKline
- Bayer
- Mylan Pharmaceuticals
- Novartis
- Upsher-Smith
- Ascend Therapeutics
- AMAG Pharmaceuticals (Lumara Health, KV Pharm/Ther-Rx Corp)
- Janssen Pharmaceuticals
- Noven Pharmaceuticals
- ProStrakan
- Shire
- Hercon Pharmaceutical
- Kremers Urban Pharmaceuticals
- Nitto Denko
- Teva Pharmaceutical Industries
- Endo International
- Teikoku USA
- Boehringer Ingelheim
- 3M
- UCB
- ParPharm

For more information visit http://www.researchandmarkets.com/research/xxttk5/global

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Related Links

http://www.researchandmarkets.com